These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36471344)

  • 1. Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels.
    Shelkowitz E; Saneto RP; Al-Hertani W; Lubout CMA; Stence NV; Brown MS; Long P; Walleigh D; Nelson JA; Perez FE; Shaw DWW; Michl EJ; Van Hove JLK
    Orphanet J Rare Dis; 2022 Dec; 17(1):423. PubMed ID: 36471344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.
    Van Hove JL; Vande Kerckhove K; Hennermann JB; Mahieu V; Declercq P; Mertens S; De Becker M; Kishnani PS; Jaeken J
    J Inherit Metab Dis; 2005; 28(5):651-63. PubMed ID: 16151895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketogenic diet, a potentially valuable therapeutic option for the management of refractory epilepsy in classical neonatal nonketotic hyperglycinemia: a case report.
    Kava MP; Robertson A; Greed L; Balasubramaniam S
    Eur J Clin Nutr; 2019 Jun; 73(6):961-965. PubMed ID: 30108280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo 1H magnetic resonance spectroscopic measurement of brain glycine levels in nonketotic hyperglycinemia.
    Gabis L; Parton P; Roche P; Lenn N; Tudorica A; Huang W
    J Neuroimaging; 2001 Apr; 11(2):209-11. PubMed ID: 11296595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid amino acids glycine, serine, and threonine in nonketotic hyperglycinemia.
    Swanson MA; Miller K; Young SP; Tong S; Ghaloul-Gonzalez L; Neira-Fresneda J; Schlichting L; Peck C; Gabel L; Friederich MW; Van Hove JLK
    J Inherit Metab Dis; 2022 Jul; 45(4):734-747. PubMed ID: 35357708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan.
    Chien YH; Hsu CC; Huang A; Chou SP; Lu FL; Lee WT; Hwu WL
    J Child Neurol; 2004 Jan; 19(1):39-42. PubMed ID: 15032382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopy of the brain of a neonate with nonketotic hyperglycinemia: in vivo-in vitro (ex vivo) correlation.
    Huisman TA; Thiel T; Steinmann B; Zeilinger G; Martin E
    Eur Radiol; 2002 Apr; 12(4):858-61. PubMed ID: 11960238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant.
    Hamosh A; McDonald JW; Valle D; Francomano CA; Niedermeyer E; Johnston MV
    J Pediatr; 1992 Jul; 121(1):131-5. PubMed ID: 1385627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia.
    Swanson MA; Coughlin CR; Scharer GH; Szerlong HJ; Bjoraker KJ; Spector EB; Creadon-Swindell G; Mahieu V; Matthijs G; Hennermann JB; Applegarth DA; Toone JR; Tong S; Williams K; Van Hove JL
    Ann Neurol; 2015 Oct; 78(4):606-18. PubMed ID: 26179960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical increase in seizure frequency with valproate in nonketotic hyperglycinemia.
    Tsuyusaki Y; Shimbo H; Wada T; Iai M; Tsuji M; Yamashita S; Aida N; Kure S; Osaka H
    Brain Dev; 2012 Jan; 34(1):72-5. PubMed ID: 21316884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive detection of increased glycine content by proton MR spectroscopy in the brains of two infants with nonketotic hyperglycinemia.
    Heindel W; Kugel H; Roth B
    AJNR Am J Neuroradiol; 1993; 14(3):629-35. PubMed ID: 8517351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia.
    Viola A; Chabrol B; Nicoli F; Confort-Gouny S; Viout P; Cozzone PJ
    Pediatr Res; 2002 Aug; 52(2):292-300. PubMed ID: 12149509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia.
    Hamosh A; Maher JF; Bellus GA; Rasmussen SA; Johnston MV
    J Pediatr; 1998 Apr; 132(4):709-13. PubMed ID: 9580775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Perampanel and a Ketogenic Diet in Nonketotic Hyperglycinemia: A Case Report.
    Daida A; Hamano SI; Ikemoto S; Hirata Y; Matsuura R; Koichihara R; Oba D; Ohashi H
    Neuropediatrics; 2020 Dec; 51(6):417-420. PubMed ID: 32176929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia.
    Bjoraker KJ; Swanson MA; Coughlin CR; Christodoulou J; Tan ES; Fergeson M; Dyack S; Ahmad A; Friederich MW; Spector EB; Creadon-Swindell G; Hodge MA; Gaughan S; Burns C; Van Hove JL
    J Pediatr; 2016 Mar; 170():234-9. PubMed ID: 26749113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical progress of neonatal non-ketotic hyperglycinemia under treatment].
    García-Pérez A; Martínez-Granero MA; Martín-Ancel AM; Bonet-Serra B; García-Muñoz MJ; García-Segura JM; Viaño J; Lama-More RA
    Rev Neurol; 2004 Oct 16-31; 39(8):727-30. PubMed ID: 15514900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonketotic Hyperglycinemia: Two Case Reports and Review.
    Poothrikovil RP; Al Thihli K; Al Futaisi A; Al Murshidi F
    Neurodiagn J; 2019; 59(3):142-151. PubMed ID: 31433733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebral blood and MRS in neonatal nonketotic hyperglycinemia.
    Manley BJ; Sokol J; Cheong JL
    Pediatr Neurol; 2010 Mar; 42(3):219-22. PubMed ID: 20159434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycine and benzoate conjugation and glycine acyltransferase activity in the developing and adult rat: possible relationships to nonketotic hyperglycinemia.
    MacDermot KD; Nelson W; Soutter V; Towne D; Schulman JD
    Dev Pharmacol Ther; 1981; 3(3):150-9. PubMed ID: 7338122
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.